Related Experiment Video
Updated: Mar 18, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Characterizing the timing and causes of death in community-acquired pneumonia
Fatimah Al-Zergani1, Alessandra Meddis2, Clara Lundetoft Clausen1
1Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
Objective:
We assessed the timing and causes of death in subjects hospitalized with community-acquired pneumonia (CAP).
Methods:
A cohort of 2918 immunocompetent adults hospitalized with CAP were followed for 90 days between 2017 and 2020. Each immediate and underlying cause of death was independently assessed by two physicians.
Results:
Overall, 19% (562/2918) of patients died within 90 days. Pneumonia-related deaths (243/562 [43%]) primarily occurred within the first two weeks of admission, and respiratory failure was the most common cause of death overall (272/562 [48%]). Later deaths were either unrelated to pneumonia (159/562 [28%]) or from unknown causes (160/562 [28%]), if they occurred out of hospital. Of deceased patients, 314/562 (56%) transitioned to palliative care within the last 7 days of life.
Conclusions:
In a contemporary cohort, CAP-related mortality occurred early, whereas later deaths were driven by comorbidities and increased frailty. Understanding the burden of CAP through specific cause-of death assessment is critical to evaluate treatment effects and to improve outcomes for increasingly frail patient populations.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...